IgG-4 related disease in ophthalmology

Area of Science:

• Ophthalmology
• Rheumatology
• Immunology

Background:

• Immunoglobulin G4-related disease (IgG4-RD) is a recently identified systemic fibro-inflammatory condition.
• Ocular involvement is common, affecting orbital and intraocular structures, and potentially other organs.

Purpose of the Study:

• To outline the diagnostic criteria and treatment strategies for IgG4-related disease affecting the eye.
• To differentiate IgG4-RD from other inflammatory ocular pathologies.

Main Methods:

• Diagnosis relies on integrated clinical, radiological, and immuno-histological examinations.
• Characteristic histopathological findings are crucial for diagnosis.
• Serum IgG4 levels alone are not definitive diagnostic markers.

Main Results:

• Histopathological and immunophenotyping assessments, combined with clinical data, are essential for accurate diagnosis.
• Corticosteroids are the primary treatment, but disease relapses can occur.
• Second-line treatments include azathioprine and mycophenolate mofetil.
• Rituximab demonstrates significant efficacy in treating relapsed IgG4-RD.

Conclusions:

• Accurate diagnosis of IgG4-RD requires a multi-faceted approach, integrating clinical, imaging, and histopathological data.
• While corticosteroids are effective, long-term management may involve other immunosuppressants or biologics like rituximab to control relapses.